Russell Investments Group
LENZ

Russell Investments Group’s LENZ Therapeutics LENZ Stock Holding History

Russell Investments Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85K Buy
14,970
+4,036
+37% +$32.5K ﹤0.01% 3499
2026
Q1 		$100K Sell
10,934
-4,527
-29% -$63.6K ﹤0.01% 3087
2025
Q4 		$247K Sell
15,461
-129,052
-89% -$3.76M ﹤0.01% 2764
2025
Q3 		$6.73M Buy
144,513
+100,282
+227% +$3.69M 0.01% 1128
2025
Q2 		$1.3M Buy
44,231
+44,227
+1,105,675% +$1.2M ﹤0.01% 1934
2025
Q1 		$103 Hold
4
– – ﹤0.01% 3753
2024
Q4 		$115 Sell
4
-9
-69% -$274 ﹤0.01% 3671
2024
Q3 		$309 Hold
13
– – ﹤0.01% 3610
2024
Q2 		$225 Buy
+13
New +$227 ﹤0.01% 3545

Other funds holding LENZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Russell Investments Group's LENZ Position: Q2 2026 in Review

Russell Investments Group increased its LENZ Therapeutics (LENZ) stake by 37% in Q2 2026, buying an estimated $32.5K and bringing the position to 14,970 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #3499.

Russell Investments Group first reported a position in LENZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.73M in Q3 2025. 45 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Russell Investments Group held 14,970 shares of LENZ Therapeutics worth $85K as of Q2 2026.
  • Russell Investments Group bought 4,036 LENZ Therapeutics shares in Q2 2026, an estimated $32.5K.
  • LENZ Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3499 holding.
  • Russell Investments Group first reported a position in LENZ Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Russell Investments Group's LENZ Therapeutics position peaked at $6.73M in Q3 2025.
  • 45 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.